Compare Essex Property Trust, Inc. (ESS) vs Globus Medical Inc. Class A Common Stock (GMED) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Essex Property Trust, Inc. vs Globus Medical Inc. Class A Common Stock — how do they compare? Essex Property Trust, Inc. trades at $268.84 (market cap $17.31B), while Globus Medical Inc. Class A Common Stock trades at $76.85 (market cap $10.25B). The key difference: Essex Property Trust, Inc. is the larger of the two by market cap, and Essex Property Trust, Inc. pays a 3.85% dividend while Globus Medical Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Essex Property Trust, Inc. for 112 Days and Globus Medical Inc. Class A Common Stock for 0 Days on average.
| ESS | GMED | |
|---|---|---|
Market Cap | $17.31B | $10.25B |
Volume | 358,204 | 1,059,528 |
Sector | Real Estate | Health |
52-Week High | $298.33 | $96.82 |
52-Week Low | $239.61 | $58.33 |
Typical Hold Time | 112 Days | 0 Days |
Enterprise Value | $23.91B | $9.76B |
Dividend Yield | 3.85% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ESS trades at $271.88, up 0.55% with neutral technical signals. The company reported mixed Q2 2026 results, beating FFO guidance but missing EPS estimates. Strong operational efficiency is evident with 67.9% gross margins and $1.07B operating cash flow. Recent developments include conference presentations and dividend declarations, while legal settlements have reduced risk overhangs. Analyst consensus shows a $300.77 price target with 38% buy ratings.
ESS demonstrates solid fundamentals with revenue growth to $1.89B and robust profitability, though elevated P/E of 41.96 suggests premium valuation. Upside potential exists from raised 2026 guidance and institutional accumulation, but risks include debt levels at $6.46B and regional real estate exposure. The stock offers income via $2.59 dividend amid cautious analyst sentiment.
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Essex Property Trust, Inc.
Essex Property Trust owns a portfolio of 253 apartment communities with over 62,000 units and is developing three additional properties with 571 units. The company focuses on owning large, high-quality properties on the West Coast in the urban and suburban submarkets of Southern California, Northern California, and Seattle.
Read more on ESS →About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →
